Cellular events in nicotine addiction

Seminars in Cell and Developmental Biology

Volumn 20, Issue 4, 2009, Pages 418-431

  Penton, Rachel E ^a   Lester, Robin A J ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Desensitization; Ion channel; Plasticity; Tolerance; Upregulation

Indexed keywords

ALPHA 3 BETA 4 NICOTINIC RECEPTOR; ALPHA 4 BETA 2 NICOTINIC RECEPTOR; ALPHA 6 BETA 2 BETA 3 NICOTINIC RECEPTOR; ALPHA 7 NICOTINIC RECEPTOR; NICOTINE; NICOTINIC RECEPTOR; UNCLASSIFIED DRUG;

AUTOREGULATION; CENTRAL NERVOUS SYSTEM; DRUG DEPENDENCE; GENE MUTATION; HOMEOSTASIS; HUMAN; NONHUMAN; REVIEW; SMOKING; TOBACCO DEPENDENCE; UPREGULATION;

NICOTIANA TABACUM;

EID: 67549127403     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcdb.2009.01.001     Document Type: Review

References (247)

1. WHO Report on the Global Tobacco Epidemic, 2008: the MPOWER package. Geneva: World Health Organization; 2008.
2. Hughes J., Keely J., and Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 99 (2004) 29-38
3. Nides M. Update on pharmacologic options for smoking cessation treatment. Am J Med 121 (2008) S20-S31
4. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008:CD000146.
5. Russell M.A. The nicotine addiction trap: a 40-year sentence for four cigarettes. Br J Addict 85 (1990) 293-300
6. Corrigall W.A., and Coen K.M. Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology 99 (1989) 473-478
7. Corrigall W.A., Franklin K.B., Coen K.M., and Clarke P.B. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology 107 (1992) 285-289
8. Dani J.A., and Mayer M.L. Structure and function of glutamate and nicotinic acetylcholine receptors. Curr Opin Neurobiol 5 (1995) 310-317
9. Brown D.A. The history of the neuronal nicotinic receptors. In: Clementi F., Fornasari D., and Gotti C. (Eds). Neuronal nicotinic receptors (2000), Springer, Berlin, New York 3-11
10. Colquhoun D., and Ogden D.C. Activation of ion channels in the frog end-plate by high concentrations of acetylcholine. J Physiol 395 (1988) 131-159
11. Wood S.J., and Slater C.R. Safety factor at the neuromuscular junction. Prog Neurobiol 64 (2001) 393-429
12. Sanes J.R., and Lichtman J.W. Induction, assembly, maturation and maintenance of a postsynaptic apparatus. Nat Rev Neurosci 2 (2001) 791-805
13. Lindstrom J. Autoimmune diseases involving nicotinic receptors. J Neurobiol 53 (2002) 656-665
14. Briggs C.A., and McAfee D.A. Long-term potentiation at nicotinic synapses in the rat superior cervical ganglion. J Physiol 404 (1988) 129-144
15. Role L.W., and Berg D.K. Nicotinic receptors in the development and modulation of CNS synapses. Neuron 16 (1996) 1077-1085
16. Jones S., Sudweeks S., and Yakel J.L. Nicotinic receptors in the brain: correlating physiology with function. Trends Neurosci 22 (1999) 555-561
17. Descarries L., Gisiger V., and Steriade M. Diffuse transmission by acetylcholine in the CNS. Prog Neurobiol 53 (1997) 603-625
18. Zoli M., Jansson A., Syková E., Agnati L.F., and Fuxe K. Volume transmission in the CNS and its relevance for neuropsychopharmacology. Trends Pharmacol Sci 20 (1999) 142-150
19. Lendvai B., and Vizi E.S. Nonsynaptic chemical transmission through nicotinic acetylcholine receptors. Physiol Rev 88 (2008) 333-349
20. Di Chiara G., and North R.A. Neurobiology of opiate abuse. Trends Pharmacol Sci 13 (1992) 185-193
21. Caggiula A.R., Donny E.C., White A.R., Chaudhri N., Booth S., Gharib M.A., et al. Cue dependency of nicotine self-administration and smoking. Pharmacol Biochem Behav 70 (2001) 515-530
22. Kelley A.E. Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron 44 (2004) 161-179
23. Hyman S., Malenka R., and Nestler E. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29 (2006) 565-598
24. Dani J.A., Ji D., and Zhou F.M. Synaptic plasticity and nicotine addiction. Neuron 31 (2001) 349-352
25. McKay B.E., Placzek A.N., and Dani J. Regulation of synaptic transmission and plasticity by neuronal nicotinic acetylcholine receptors. Biochem Pharmacol 74 (2007) 1120-1133
26. Mansvelder HD, Mertz M, Role LW. Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits. Semin Cell Dev Biol 2009, doi:10.1016/j.semcdb.2009.01.007, this issue.
27. Role L.W. Diversity in primary structure and function of neuronal nicotinic acetylcholine receptor channels. Curr Opin Neurobiol 2 (1992) 254-262
28. Colquhoun L.M., and Patrick J.W. Pharmacology of neuronal nicotinic acetylcholine receptor subtypes. Adv Pharmacol 39 (1997) 191-220
29. Dani J., and Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 47 (2007) 699-729
30. Karlin A. Structure of nicotinic acetylcholine receptors. Curr Opin Neurobiol 3 (1993) 299-309
31. Sargent P.B. The diversity of neuronal nicotinic acetylcholine receptors. Annu Rev Neurosci 16 (1993) 403-443
32. McGehee D.S., and Role L.W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 57 (1995) 521-546
33. Lindstrom J. Nicotinic acetylcholine receptors in health and disease. Mol Neurobiol 15 (1997) 193-222
34. Lukas R.J., Changeux J.P., Le Novère N., Albuquerque E.X., Balfour D.J., Berg D.K., et al. International union of pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev 51 (1999) 397-401
35. Cordero-Erausquin M., Marubio L.M., Klink R., and Changeux J.P. Nicotinic receptor function: new perspectives from knockout mice. Trends Pharmacol Sci 21 (2000) 211-217
36. Mongan N.P., Baylis H.A., Adcock C., Smith G.R., Sansom M.S., and Sattelle D.B. An extensive and diverse gene family of nicotinic acetylcholine receptor α subunits in Caenorhabditis elegans. Receptors Channels 6 (1998) 213-228
37. Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrick J., et al. Distribution of α2, α3, α4, and β2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J Comp Neurol 284 (1989) 314-335
38. Brussaard A.B., Yang X., Doyle J.P., Huck S., and Role L.W. Developmental regulation of multiple nicotinic AChR channel subtypes in embryonic chick habenula neurons: contributions of both the α2 and α4 subunit genes. Pflugers Arch 429 (1994) 27-43
39. McIntosh J.M., Gardner S., Luo S., Garrett J.E., and Yoshikami D. Conus peptides: novel probes for nicotinic acetylcholine receptor structure and function. Eur J Pharmacol 393 (2000) 205-208
40. Janes R.W. α-Conotoxins as selective probes for nicotinic acetylcholine receptor subclasses. Curr Opin Pharmacol 5 (2005) 280-292
41. Picciotto M.R., Caldarone B.J., Brunzell D.H., Zachariou V., Stevens T.R., and King S.L. Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications. Pharmacol Ther 92 (2001) 89-108
42. Picciotto M.R., Zoli M., Rimondini R., Léna C., Marubio L.M., Pich E.M., et al. Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature 391 (1998) 173-177
43. Fenster C.P., Rains M.F., Noerager B., Quick M.W., and Lester R.A. Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine. J Neurosci 17 (1997) 5747-5759
44. Schoepfer R., Whiting P., Esch F., Blacher R., Shimasaki S., and Lindstrom J. cDNA clones coding for the structural subunit of a chicken brain nicotinic acetylcholine receptor. Neuron 1 (1988) 241-248
45. Flores C.M., Rogers S.W., Pabreza L.A., Wolfe B.B., and Kellar K.J. A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol 41 (1992) 31-37
46. Shafaee N., Houng M., Truong A., Viseshakul N., Figl A., and Sandhu S. Pharmacological similarities between native brain and heterologously expressed α4β2 nicotinic receptors. Br J Pharmacol 128 (1999) 1291-1299
47. Picciotto M.R., Zoli M., Léna C., Bessis A., Lallemand Y., Le Novère N., et al. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature 374 (1995) 65-67
48. Marubio L.M., del Mar Arroyo-Jimenez M., Cordero-Erausquin M., Léna C., Le Novère N., de Kerchove d'Exaerde A., et al. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 398 (1999) 805-810
49. Conroy W.G., Vernallis A.B., and Berg D.K. The α5 gene product assembles with multiple acetylcholine receptor subunits to form distinctive receptor subtypes in brain. Neuron 9 (1992) 679-691
50. Ramirez-Latorre J., Yu C.R., Qu X., Perin F., Karlin A., and Role L. Functional contributions of α5 subunit to neuronal acetylcholine receptor channels. Nature 380 (1996) 347-351
51. Wang F., Gerzanich V., Wells G.B., Anand R., Peng X., Keyser K., et al. Assembly of human neuronal nicotinic receptor α5 subunits with α3, β2, and β4 subunits. J Biol Chem 271 (1996) 17656-17665
52. Porter J.T., Cauli B., Tsuzuki K., Lambolez B., Rossier J., and Audinat E. Selective excitation of subtypes of neocortical interneurons by nicotinic receptors. J Neurosci 19 (1999) 5228-5235
53. Cooper E., Couturier S., and Ballivet M. Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor. Nature 350 (1991) 235-238
54. Nelson M.E., Kuryatov A., Choi C.H., Zhou Y., and Lindstrom J. Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors. Mol Pharmacol 63 (2003) 332-341
55. + efflux in cortex and thalamus and alters relative expression of α4 and β2 subunits. Mol Pharmacol 73 (2008) 1796-1807
56. Marks M.J., Burch J.B., and Collins A.C. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J Pharmacol Exp Ther 226 (1983) 817-825
57. Schwartz R.D., and Kellar K.J. Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science 220 (1983) 214-216
58. Wonnacott S. The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol Sci 11 (1990) 216-219
59. Corrigall W.A., Coen K.M., and Adamson K.L. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653 (1994) 278-284
60. Maskos U., Molles B.E., Pons S., Besson M., Guiard B.P., Guilloux J.P., et al. Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436 (2005) 103-107
61. Pons S., Fattore L., Cossu G., Tolu S., Porcu E., McIntosh J.M., et al. Crucial role of α4 and α6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration. J Neurosci 28 (2008) 12318-12327
62. Tapper A.R., McKinney S.L., Nashmi R., Schwarz J., Deshpande P., Labarca C., et al. Nicotine activation of α4* receptors: sufficient for reward, tolerance, and sensitization. Science 306 (2004) 1029-1032
63. Klink R., de Kerchove d'Exaerde A., Zoli M., and Changeux J.P. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J Neurosci 21 (2001) 1452-1463
64. Mansvelder H., Keath J.R., and McGehee D.S. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33 (2002) 905-919
65. Pidoplichko V.I., Noguchi J., Areola O.O., Liang Y., Peterson J., Zhang T., et al. Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction. Learn Mem 11 (2004) 60-69
66. Nashmi R., Xiao C., Deshpande P., McKinney S., Grady S., Whiteaker P., et al. Chronic nicotine cell specifically upregulates functional α4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J Neurosci 27 (2007) 8202-8218
67. Picciotto M., Addy N.A., Mineur Y.S., and Brunzell D. It is not "Either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Prog Neurobiol 84 (2008) 329-342
68. Couturier S., Bertrand D., Matter J.M., Hernandez M.C., Bertrand S., Millar N., et al. A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homo-oligomeric channel blocked by α-BTX. Neuron 5 (1990) 847-856
69. Séguéla P., Wadiche J., Dineley-Miller K., Dani J.A., and Patrick J.W. Molecular cloning, functional properties, and distribution of rat brain α7: a nicotinic cation channel highly permeable to calcium. J Neurosci 13 (1993) 596-604
70. Alkondon M., Pereira E.F., Wonnacott S., and Albuquerque E.X. Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist. Mol Pharmacol 41 (1992) 802-808
71. Zorumski C.F., Thio L.L., Isenberg K.E., and Clifford D.B. Nicotinic acetylcholine currents in cultured postnatal rat hippocampal neurons. Mol Pharmacol 41 (1992) 931-936
72. Dineley K.T., and Patrick J.W. Amino acid determinants of α7 nicotinic acetylcholine receptor surface expression. J Biol Chem 275 (2000) 13974-13985
73. Anand R., Bason L., Saedi M.S., Gerzanich V., Peng X., and Lindstrom J. Reporter epitopes: a novel approach to examine transmembrane topology of integral membrane proteins applied to the α1 subunit of the nicotinic acetylcholine receptor. Biochemistry 32 (1993) 9975-9984
74. Chen D., and Patrick J.W. The α-bungarotoxin-binding nicotinic acetylcholine receptor from rat brain contains only the α7 subunit. J Biol Chem 272 (1997) 24024-24029
75. Drisdel R.C., and Green W.N. Neuronal α-bungarotoxin receptors are α7 subunit homomers. J Neurosci 20 (2000) 133-139
76. Orr-Urtreger A., Göldner F.M., Saeki M., Lorenzo I., Goldberg L., De Biasi M., et al. Mice deficient in the α7 neuronal nicotinic acetylcholine receptor lack α-bungarotoxin binding sites and hippocampal fast nicotinic currents. J Neurosci 17 (1997) 9165-9171
77. Khiroug S.S., Harkness P.C., Lamb P.W., Sudweeks S.N., Khiroug L., Millar N.S., et al. Rat nicotinic ACh receptor α7 and β2 subunits co-assemble to form functional heteromeric nicotinic receptor channels. J Physiol 540 (2002) 425-434
78. Yu C.R., and Role L.W. Functional contribution of the α7 subunit to multiple subtypes of nicotinic receptors in embryonic chick sympathetic neurones. J Physiol 509 Part 3 (1998) 651-665
79. Alkondon M., and Albuquerque E.X. Initial characterization of the nicotinic acetylcholine receptors in rat hippocampal neurons. J Recept Res 11 (1991) 1001-1021
80. Alkondon M., Pereira E.F., and Albuquerque E.X. α-Bungarotoxin- and methyllycaconitine-sensitive nicotinic receptors mediate fast synaptic transmission in interneurons of rat hippocampal slices. Brain Res 810 (1998) 257-263
81. Frazier C.J., Buhler A.V., Weiner J.L., and Dunwiddie T.V. Synaptic potentials mediated via α-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons. J Neurosci 18 (1998) 8228-8235
82. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci 20 (1997) 92-98
83. Besson M., Granon S., Mameli-Engvall M., Cloëz-Tayarani I., Maubourguet N., Cormier A., et al. Long-term effects of chronic nicotine exposure on brain nicotinic receptors. Proc Natl Acad Sci U S A 104 (2007) 8155-8160
84. Walters C., Brown S., Changeux J., Martin B., and Damaj M.I. The β2 but not α7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology 184 (2006) 339-344
85. Markou A., and Paterson N.E. The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat. Nicotine Tob Res 3 (2001) 361-373
86. Salas R., Main A., Gangitano D., and De Biasi M. Decreased withdrawal symptoms but normal tolerance to nicotine in mice null for the α7 nicotinic acetylcholine receptor subunit. Neuropharmacology 53 (2007) 863-869
87. Mansvelder H.D., and McGehee D.S. Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron 27 (2000) 349-357
88. Saal D., Dong Y., Bonci A., and Malenka R. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37 (2003) 577-582
89. Levin E. Nicotinic receptor subtypes and cognitive function. J Neurobiol 53 (2002) 633-640
90. Ji D., Lape R., and Dani J.A. Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron 31 (2001) 131-141
91. Adler L.E., Olincy A., Waldo M., Harris J.G., Griffith J., Stevens K., et al. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull 24 (1998) 189-202
92. Duvoisin R.M., Deneris E.S., Patrick J., and Heinemann S. The functional diversity of the neuronal nicotinic acetylcholine receptors is increased by a novel subunit: β4. Neuron 3 (1989) 487-496
93. Dineley-Miller K., and Patrick J. Gene transcripts for the nicotinic acetylcholine receptor subunit, β4, are distributed in multiple areas of the rat central nervous system. Brain Res Mol Brain Res 16 (1992) 339-344
94. Zoli M., Le Novère N., Hill J.A., and Changeux J.P. Developmental regulation of nicotinic ACh receptor subunit mRNAs in the rat central and peripheral nervous systems. J Neurosci 15 (1995) 1912-1939
95. Winzer-Serhan U.H., and Leslie F.M. Codistribution of nicotinic acetylcholine receptor subunit α3 and β4 mRNAs during rat brain development. J Comp Neurol 386 (1997) 540-554
96. Quick M.W., Ceballos R.M., Kasten M., McIntosh J.M., and Lester R.A. α3β4 subunit-containing nicotinic receptors dominate function in rat medial habenula neurons. Neuropharmacology 38 (1999) 769-783
97. Covernton P.J., Kojima H., Sivilotti L.G., Gibb A.J., and Colquhoun D. Comparison of neuronal nicotinic receptors in rat sympathetic neurones with subunit pairs expressed in xenopus oocytes. J Physiol 481 Part 1 (1994) 27-34
98. Conroy W.G., and Berg D.K. Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions. J Biol Chem 270 (1995) 4424-4431
99. Sivilotti L.G., McNeil D.K., Lewis T.M., Nassar M.A., Schoepfer R., and Colquhoun D. Recombinant nicotinic receptors, expressed in Xenopus oocytes, do not resemble native rat sympathetic ganglion receptors in single-channel behaviour. J Physiol 500 Part 1 (1997) 123-138
100. Boulter J., O'Shea-Greenfield A., Duvoisin R.M., Connolly J.G., Wada E., Jensen A., et al. α3, α5, and β4: three members of the rat neuronal nicotinic acetylcholine receptor-related gene family form a gene cluster. J Biol Chem 265 (1990) 4472-4482
101. Groot-Kormelink P.J., Luyten W.H., Colquhoun D., and Sivilotti L.G. A reporter mutation approach shows incorporation of the "orphan" subunit β3 into a functional nicotinic receptor. J Biol Chem 273 (1998) 15317-15320
102. 3H]epibatidine labels nicotinic receptors in rat brain: an autoradiographic study. J Pharmacol Exp Ther 275 (1995) 1030-1034
103. 125I]-epibatidine. Br J Pharmacol 131 (2000) 729-739
104. Perry D.C., Xiao Y., Nguyen H.N., Musachio J.L., Dávila-García M.I., and Kellar K.J. Measuring nicotinic receptors with characteristics of α4β2,α3β2 and α3β4 subtypes in rat tissues by autoradiography. J Neurochem 82 (2002) 468-481
105. Zoli M., Léna C., Picciotto M.R., and Changeux J.P. Identification of four classes of brain nicotinic receptors using β2 mutant mice. J Neurosci 18 (1998) 4461-4472
106. De Biasi M. Nicotinic mechanisms in the autonomic control of organ systems. J Neurobiol 53 (2002) 568-579
107. Rassadi S., Krishnaswamy A., Pié B., McConnell R., Jacob M.H., and Cooper E. A null mutation for the α3 nicotinic acetylcholine (ACh) receptor gene abolishes fast synaptic activity in sympathetic ganglia and reveals that ACh output from developing preganglionic terminals is regulated in an activity-dependent retrograde manner. J Neurosci 25 (2005) 8555-8566
108. Vachon M.P., and Miliaressis E. Dorsal diencephalic self-stimulation: a movable electrode mapping study. Behav Neurosci 106 (1992) 981-991
109. Salas R., Pieri F., and De Biasi M. Decreased signs of nicotine withdrawal in mice null for the β4 nicotinic acetylcholine receptor subunit. J Neurosci 24 (2004) 10035-10039
110. Glick S.D., Maisonneuve I.M., Kitchen B.A., and Fleck M.W. Antagonism of α3β4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration. Eur J Pharmacol 438 (2002) 99-105
111. Taraschenko O.D., Shulan J.M., Maisonneuve I.M., and Glick S.D. 18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbens. Synapse 61 (2007) 547-560
112. Glick S.D., Ramirez R.L., Livi J.M., and Maisonneuve I.M. 18-methoxycoronaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in rats. Eur J Pharmacol 537 (2006) 94-98
113. Panchal V., Taraschenko O.D., Maisonneuve I.M., and Glick S.D. Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridine. Eur J Pharmacol 525 (2005) 98-104
114. Glick S.D., Maisonneuve I.M., Visker K.E., Fritz K.A., Bandarage U.K., and Kuehne M.E. 18-Methoxycoronardine attenuates nicotine-induced dopamine release and nicotine preferences in rats. Psychopharmacology 139 (1998) 274-280
115. Gerzanich V., Kuryatov A., Anand R., and Lindstrom J. "Orphan" α6 nicotinic AChR subunit can form a functional heteromeric acetylcholine receptor. Mol Pharmacol 51 (1997) 320-327
116. Cartier G.E., Yoshikami D., Gray W.R., Luo S., Olivera B.M., and McIntosh J.M. A new α-conotoxin which targets α3β2 nicotinic acetylcholine receptors. J Biol Chem 271 (1996) 7522-7528
117. Grady S.R., Meinerz N.M., Cao J., Reynolds A.M., Picciotto M.R., Changeux J.P., et al. Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum. J Neurochem 76 (2001) 258-268
118. Cui C., Booker T.K., Allen R.S., Grady S.R., Whiteaker P., Marks M.J., et al. The β3 nicotinic receptor subunit: a component of α-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors. J Neurosci 23 (2003) 11045-11053
119. Le Novère N., Zoli M., and Changeux J.P. Neuronal nicotinic receptor α6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. Eur J Neurosci 8 (1996) 2428-2439
120. Göldner F.M., Dineley K.T., and Patrick J.W. Immunohistochemical localization of the nicotinic acetylcholine receptor subunit α6 to dopaminergic neurons in the substantia nigra and ventral tegmental area. Neuroreport 8 (1997) 2739-2742
121. Luetje C.W. Getting past the asterisk: the subunit composition of presynaptic nicotinic receptors that modulate striatal dopamine release. Mol Pharmacol 65 (2004) 1333-1335
122. Kulak J.M., Nguyen T.A., Olivera B.M., and McIntosh J.M. α-Conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes. J Neurosci 17 (1997) 5263-5270
123. Champtiaux N., Gotti C., Cordero-Erausquin M., David D.J., Przybylski C., Léna C., et al. Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J Neurosci 23 (2003) 7820-7829
124. Salminen O., Murphy K.L., McIntosh J.M., Drago J., Marks M.J., Collins A.C., et al. Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Mol Pharmacol 65 (2004) 1526-1535
125. Whiteaker P., Peterson C.G., Xu W., McIntosh J.M., Paylor R., Beaudet A.L., et al. Involvement of the α3 subunit in central nicotinic binding populations. J Neurosci 22 (2002) 2522-2529
126. 3H]dopamine release from rat striatal synaptosomes and slices. J Neurochem 70 (1998) 1069-1076
127. Wonnacott S., Sidhpura N., and Balfour D.J. Nicotine: from molecular mechanisms to behaviour. Curr Opin Pharmacol 5 (2005) 53-59
128. Zhou F.M., Liang Y., and Dani J.A. Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat Neurosci 4 (2001) 1224-1229
129. Gerdeman G.L., Partridge J.G., Lupica C.R., and Lovinger D.M. It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci 26 (2003) 184-192
130. Grady S., Salminen O., Laverty D.C., Whiteaker P., Mcintosh J., Collins A., et al. The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum. Biochem Pharmacol 74 (2007) 1235-1246
131. Elgoyhen A.B., Johnson D.S., Boulter J., Vetter D.E., and Heinemann S. α9: An acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 79 (1994) 705-715
132. Elgoyhen A.B., Vetter D.E., Katz E., Rothlin C.V., Heinemann S.F., and Boulter J. α10: A determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proc Natl Acad Sci U S A 98 (2001) 3501-3506
133. Fuchs P.A. Synaptic transmission at vertebrate hair cells. Curr Opin Neurobiol 6 (1996) 514-519
134. Glowatzki E., and Fuchs P.A. Cholinergic synaptic inhibition of inner hair cells in the neonatal mammalian cochlea. Science 288 (2000) 2366-2368
135. Schoepfer R., Conroy W.G., Whiting P., Gore M., and Lindstrom J. Brain, α-bungarotoxin binding protein cDNAs and mAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily. Neuron 5 (1990) 35-48
136. Keyser K.T., Britto L.R., Schoepfer R., Whiting P., Cooper J., Conroy W., et al. Three subtypes of α-bungarotoxin-sensitive nicotinic acetylcholine receptors are expressed in chick retina. J Neurosci 13 (1993) 442-454
137. Gotti C., Hanke W., Maury K., Moretti M., Ballivet M., Clementi F., et al. Pharmacology and biophysical properties of α7 and α7α8 α-bungarotoxin receptor subtypes immunopurified from the chick optic lobe. Eur J Neurosci 6 (1994) 1281-1291
138. Mulle C., Vidal C., Benoit P., and Changeux J.P. Existence of different subtypes of nicotinic acetylcholine receptors in the rat habenulo-interpeduncular system. J Neurosci 11 (1991) 2588-2597
139. Ishii K., Wong J.K., and Sumikawa K. Comparison of α2 nicotinic acetylcholine receptor subunit mRNA expression in the central nervous system of rats and mice. J Comp Neurol 493 (2005) 241-260
140. Forsayeth J.R., and Kobrin E. Formation of oligomers containing the β3 and β4 subunits of the rat nicotinic receptor. J Neurosci 17 (1997) 1531-1538
141. Berrettini W., Yuan X., Tozzi F., Song K., Francks C., Chilcoat H., et al. α5/α3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol Psychiatry 13 (2008) 368-373
142. Bierut L.J., Stitzel J.A., Wang J.C., Hinrichs A.L., Grucza R.A., Xuei X., et al. Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry 165 (2008) 1163-1171
143. Thorgeirsson T.E., Geller F., Sulem P., Rafnar T., Wiste A., Magnusson K.P., et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452 (2008) 638-642
144. Bierut L.J., Madden P.A., Breslau N., Johnson E.O., Hatsukami D., Pomerleau O.F., et al. Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet 16 (2007) 24-35
145. Breitling L.P., Dahmen N., Mittelstraß K., Illig T., Rujescu D., Raum E., et al. Smoking cessation and variations in nicotinic acetylcholine receptor subunits α5, α3, and β4 genes. Biol Psychiatry (2008) 10.1016/j. biopsych.2008.10.004
146. Conti D.V., Lee W., Li D., Liu J., Van Den Berg D., Thomas P.D., et al. Nicotinic acetylcholine receptor β2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. Hum Mol Genet 17 (2008) 2834-2848
147. Nestler E.J. Cellular responses to chronic treatment with drugs of abuse. Crit Rev Neurobiol 7 (1993) 23-39
148. Picciotto M., and Corrigall W.A. Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics. J Neurosci 22 (2002) 3338-3341
149. Dani J.A., and Heinemann S. Molecular and cellular aspects of nicotine abuse. Neuron 16 (1996) 905-908
150. Gentry C.L., and Lukas R.J. Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure. Curr Drug Targets CNS Neurol Disord 1 (2002) 359-385
151. Collins A.C., Romm E., and Wehner J.M. Nicotine tolerance: an analysis of the time course of its development and loss in the rat. Psychopharmacology 96 (1988) 7-14
152. 3H]nicotine binding in human postmortem brain. J Pharmacol Exp Ther 282 (1997) 7-13
153. Quick M., and Lester R. Desensitization of neuronal nicotinic receptors. J Neurobiol 53 (2002) 457-478
154. Miller R.P., Rotenberg K.S., and Adir J. Effect of dose on the pharmacokinetics of intravenous nicotine in the rat. Drug Metab Dispos 5 (1977) 436-443
155. Rotenberg K.S., and Adir J. Pharmacokinetics of nicotine in rats after multiple-cigarette smoke exposure. Toxicol Appl Pharmacol 69 (1983) 1-11
156. 3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs. J Neurochem 45 (1985) 427-433
157. Collins A.C., Luo Y., Selvaag S., and Marks M.J. Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion. J Pharmacol Exp Ther 271 (1994) 125-133
158. Peng X., Gerzanich V., Anand R., Whiting P.J., and Lindstrom J. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol Pharmacol 46 (1994) 523-530
159. Gopalakrishnan M., Monteggia L.M., Anderson D.J., Molinari E.J., Piattoni-Kaplan M., Donnelly-Roberts D., et al. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine α4 β2 receptor. J Pharmacol Exp Ther 276 (1996) 289-297
160. Whiteaker P., Sharples C.G., and Wonnacott S. Agonist-induced up-regulation of α4β2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition. Mol Pharmacol 53 (1998) 950-962
161. Sabey K., Paradiso K., Zhang J., and Steinbach J.H. Ligand binding and activation of rat nicotinic α4β2 receptors stably expressed in HEK293 cells. Mol Pharmacol 55 (1999) 58-66
162. Peng X., Gerzanich V., Anand R., Wang F., and Lindstrom J. Chronic nicotine treatment up-regulates α3 and α7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y. Mol Pharmacol 51 (1997) 776-784
163. Nashmi R., and Lester H. Cell autonomy, receptor autonomy, and thermodynamics in nicotine receptor up-regulation. Biochem Pharmacol 74 (2007) 1145-1154
164. Fenster C.P., Whitworth T.L., Sheffield E.B., Quick M.W., and Lester R.A. Upregulation of surface α4β2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine. J Neurosci 19 (1999) 4804-4814
165. Benowitz N.L., Porchet H., and Jacob P. Nicotine dependence and tolerance in man: pharmacokinetic and pharmacodynamic investigations. Prog Brain Res 79 (1989) 279-287
166. Katz B., and Thesleff S. A study of the desensitization produced by acetylcholine at the motor end-plate. J Physiol 138 (1957) 63-80
167. Fonck C., Cohen B.N., Nashmi R., Whiteaker P., Wagenaar D.A., Rodrigues-Pinguet N., et al. Novel seizure phenotype and sleep disruptions in knock-in mice with hypersensitive α4* nicotinic receptors. J Neurosci 25 (2005) 11396-11411
168. Green W.N. Ion channel assembly: creating structures that function. J Gen Physiol 113 (1999) 163-170
169. Millar N.S., and Harkness P.C. Assembly and trafficking of nicotinic acetylcholine receptors. Mol Membr Biol 25 (2008) 279-292
170. Marks M.J., Pauly J.R., Gross S.D., Deneris E.S., Hermans-Borgmeyer I., Heinemann S.F., et al. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci 12 (1992) 2765-2784
171. Gopalakrishnan M., Molinari E.J., and Sullivan J.P. Regulation of human α4β2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways. Mol Pharmacol 52 (1997) 524-534
172. Rothhut B., Romano S.J., Vijayaraghavan S., and Berg D.K. Post-translational regulation of neuronal acetylcholine receptors stably expressed in a mouse fibroblast cell line. J Neurobiol 29 (1996) 115-125
173. Bencherif M., Fowler K., Lukas R.J., and Lippiello P.M. Mechanisms of up-regulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain. J Pharmacol Exp Ther 275 (1995) 987-994
174. Kuryatov A., Luo J., Cooper J., and Lindstrom J. Nicotine acts as a pharmacological chaperone to up-regulate human α4β2 acetylcholine receptors. Mol Pharmacol 68 (2005) 1839-1851
175. Jia L., Flotildes K., Li M., and Cohen B.N. Nicotine trapping causes the persistent desensitization of α4β2 nicotinic receptors expressed in oocytes. J Neurochem 84 (2003) 753-766
176. Sallette J., Bohler S., Benoit P., Soudant M., Pons S., Le Novère N., et al. An extracellular protein microdomain controls up-regulation of neuronal nicotinic acetylcholine receptors by nicotine. J Biol Chem 279 (2004) 18767-18775
177. Sallette J., Pons S., Devillers-Thiery A., Soudant M., Prado de Carvalho L., Changeux J., et al. Nicotine upregulates its own receptors through enhanced intracellular maturation. Neuron 46 (2005) 595-607
178. Marks M.J., Grady S.R., and Collins A.C. Downregulation of nicotinic receptor function after chronic nicotine infusion. J Pharmacol Exp Ther 266 (1993) 1268-1276
179. Buisson B., and Bertrand D. Chronic exposure to nicotine upregulates the human α4β2 nicotinic acetylcholine receptor function. J Neurosci 21 (2001) 1819-1829
180. Vallejo Y.F., Buisson B., Bertrand D., and Green W.N. Chronic nicotine exposure upregulates nicotinic receptors by a novel mechanism. J Neurosci 25 (2005) 5563-5572
181. Mao D., Perry D., Yasuda R., Wolfe B., and Kellar K. The α4β2α5 nicotinic cholinergic receptor in rat brain is resistant to up-regulation by nicotine in vivo. J Neurochem 104 (2008) 446-456
182. Pauly J.R., Marks M.J., Gross S.D., and Collins A.C. An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment. J Pharmacol Exp Ther 258 (1991) 1127-1136
183. Nguyen H.N., Rasmussen B.A., and Perry D. Binding and functional activity of nicotinic cholinergic receptors in selected rat brain regions are increased following long-term but not short-term nicotine treatment. J Neurochem 90 (2004) 40-49
184. Rowell P.P., and Wonnacott S. Evidence for functional activity of up-regulated nicotine binding sites in rat striatal synaptosomes. J Neurochem 55 (1990) 2105-2110
185. Marshall D.L., Redfern P.H., and Wonnacott S. Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated rats. J Neurochem 68 (1997) 1511-1519
186. Grilli M., Parodi M., Raiteri M., and Marchi M. Chronic nicotine differentially affects the function of nicotinic receptor subtypes regulating neurotransmitter release. J Neurochem 93 (2005) 1353-1360
187. Parker S.L., Fu Y., McAllen K., Luo J., McIntosh J.M., Lindstrom J.M., et al. Up-regulation of brain nicotinic acetylcholine receptors in the rat during long-term self-administration of nicotine: disproportionate increase of the α6 subunit. Mol Pharmacol 65 (2004) 611-622
188. McCallum S.E., Parameswaran N., Bordia T., Fan H., Tyndale R.F., Langston J.W., et al. Increases in α4* but not α3*/α6* nicotinic receptor sites and function in the primate striatum following chronic oral nicotine treatment. J Neurochem 96 (2006) 1028-1041
189. Visanji N.P., Mitchell S.N., O'Neill M.J., and Duty S. Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and α6 and β3 nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars compacta of the rat. Neuropharmacology 50 (2006) 36-46
190. 3H]dopamine release from mouse striatal synaptosomes and response to chronic l-nicotine treatment. J Pharmacol Exp Ther 282 (1997) 32-43
191. Walsh H., Govind A.P., Mastro R., Hoda J.C., Bertrand D., Vallejo Y., et al. Up-regulation of nicotinic receptors by nicotine varies with receptor subtype. J Biol Chem 283 (2008) 6022-6032
192. Wang F., Nelson M.E., Kuryatov A., Olale F., Cooper J., Keyser K., et al. Chronic nicotine treatment up-regulates human α3β2 but not α3β4 acetylcholine receptors stably transfected in human embryonic kidney cells. J Biol Chem 273 (1998) 28721-28732
193. Kawai H., and Berg D.K. Nicotinic acetylcholine receptors containing α7 subunits on rat cortical neurons do not undergo long-lasting inactivation even when up-regulated by chronic nicotine exposure. J Neurochem 78 (2001) 1367-1378
194. Everitt B., and Robbins T. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8 (2005) 1481-1489
195. Jacobs E.H., Smit A.B., de Vries T.J., and Schoffelmeer A.N. Neuroadaptive effects of active versus passive drug administration in addiction research. Trends Pharmacol Sci 24 (2003) 566-573
196. Nestler E. Is there a common molecular pathway for addiction?. Nat Neurosci 8 (2005) 1445-1449
197. Konu O., Kane J.K., Barrett T., Vawter M.P., Chang R., Ma J.Z., et al. Region-specific transcriptional response to chronic nicotine in rat brain. Brain Res 909 (2001) 194-203
198. Yeom M., Shim I., Lee H.J., and Hahm D.H. Proteomic analysis of nicotine-associated protein expression in the striatum of repeated nicotine-treated rats. Biochem Biophys Res Commun 326 (2005) 321-328
199. Katsura M., Mohri Y., Shuto K., Hai-Du Y., Amano T., Tsujimura A., et al. Up-regulation of L-type voltage-dependent calcium channels after long term exposure to nicotine in cerebral cortical neurons. J Biol Chem 277 (2002) 7979-7988
200. Hayashida S., Katsura M., Torigoe F., Tsujimura A., and Ohkuma S. Increased expression of L-type high voltage-gated calcium channel α1 and α2/δ subunits in mouse brain after chronic nicotine administration. Brain Res Mol Brain Res 135 (2005) 280-284
201. Zhang X.F., Hu X.T., and White F.J. Whole-cell plasticity in cocaine withdrawal: reduced sodium currents in nucleus accumbens neurons. J Neurosci 18 (1998) 488-498
202. Zhang X.F., Cooper D.C., and White F.J. Repeated cocaine treatment decreases whole-cell calcium current in rat nucleus accumbens neurons. J Pharmacol Exp Ther 301 (2002) 1119-1125
203. Cooper D.C., Moore S.J., Staff N.P., and Spruston N. Psychostimulant-induced plasticity of intrinsic neuronal excitability in ventral subiculum. J Neurosci 23 (2003) 9937-9946
204. + channels in rat nucleus accumbens neurons. J Neurophysiol 92 (2004) 1597-1607
205. Nasif F.J., Sidiropoulou K., Hu X.T., and White F. Repeated cocaine administration increases membrane excitability of pyramidal neurons in the rat medial prefrontal cortex. J Pharmacol Exp Ther 312 (2005) 1305-1313
206. Dong Y., Nasif F.J., Tsui J.J., Ju W.Y., Cooper D., Hu X.T., et al. Cocaine-induced plasticity of intrinsic membrane properties in prefrontal cortex pyramidal neurons: adaptations in potassium currents. J Neurosci 25 (2005) 936-940
207. Nasif F.J., Hu X.T., and White F. Repeated cocaine administration increases voltage-sensitive calcium currents in response to membrane depolarization in medial prefrontal cortex pyramidal neurons. J Neurosci 25 (2005) 3674-3679
208. Vernino S., Amador M., Luetje C.W., Patrick J., and Dani J.A. Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors. Neuron 8 (1992) 127-134
209. 2+ ions in nicotinic facilitation of GABA release in mouse thalamus. J Neurosci 17 (1997) 576-585
210. 2+ permeability of mouse and chick nicotinic acetylcholine receptors expressed in transiently transfected human cells. J Physiol 507 Part 3 (1998) 749-757
211. Flavell S.W., and Greenberg M.E. Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system. Annu Rev Neurosci 31 (2008) 563-590
212. Rezvani K., Teng Y., Shim D., and De Biasi M. Nicotine regulates multiple synaptic proteins by inhibiting proteasomal activity. J Neurosci 27 (2007) 10508-10519
213. Vezina P., McGehee D.S., and Green W.N. Exposure to nicotine and sensitization of nicotine-induced behaviors. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 1625-1638
214. Wang F., Chen H., Steketee J., and Sharp B.M. Upregulation of ionotropic glutamate receptor subunits within specific mesocorticolimbic regions during chronic nicotine self-administration. Neuropsychopharmacology 32 (2007) 103-109
215. Delibas N., Doguc D.K., Sutcu R., Eroglu E., and Gökalp O. Effect of nicotine on hippocampal nicotinic acetylcholine α7 receptor and NMDA receptor subunits 2A and 2B expression in young and old rats. Int J Neurosci 115 (2005) 1151-1163
216. Wall A., Gong Z.H., Johnson A.E., Meyerson B., and Zhang X. Cross-tolerance in drug response and differential changes in central nicotinic and N-methyl-d-aspartate receptor binding following chronic treatment with either (+)- or (-)-nicotine. Psychopharmacology 148 (2000) 186-195
217. Levin E., Tizabi Y., Rezvani A., Caldwell D.P., Petro A., and Getachew B. Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding. Brain Res 1041 (2005) 132-142
218. Vieyra-Reyes P., Picciotto M., and Mineur Y.S. Voluntary oral nicotine intake in mice down-regulates GluR2 but does not modulate depression-like behaviors. Neurosci Lett 434 (2008) 18-22
219. Kane J.K., Hwang Y., Konu O., Loughlin S.E., Leslie F.M., and Li M.D. Regulation of Homer and Group I metabotropic glutamate receptors by nicotine. Eur J Neurosci 21 (2005) 1145-1154
220. Li S.P., Park M.S., Bahk J.Y., and Kim M.O. Chronic nicotine and smoking exposure decreases GABA(B1) receptor expression in the rat hippocampus. Neurosci Lett 334 (2002) 135-139
221. Li S.P., Park M.S., Kim J.H., and Kim M.O. Chronic nicotine and smoke treatment modulate dopaminergic activities in ventral tegmental area and nucleus accumbens and the gamma-aminobutyric acid type B receptor expression of the rat prefrontal cortex. J Neurosci Res 78 (2004) 868-879
222. Amantea D., Tessari M., and Bowery N.G. Reduced G-protein coupling to the GABAB receptor in the nucleus accumbens and the medial prefrontal cortex of the rat after chronic treatment with nicotine. Neurosci Lett 355 (2004) 161-164
223. Fung Y.K., Schmid M.J., Anderson T.M., and Lau Y.S. Effects of nicotine withdrawal on central dopaminergic systems. Pharmacol Biochem Behav 53 (1996) 635-640
224. Le Foll B., Diaz J., and Sokoloff P. Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats. Synapse 47 (2003) 176-183
225. Kenny P.J., File S.E., and Rattray M. Nicotine regulates 5-HT(1A) receptor gene expression in the cerebral cortex and dorsal hippocampus. Eur J Neurosci 13 (2001) 1267-1271
226. Xu Z., Seidler F.J., Cousins M.M., Slikker W., and Slotkin T.A. Adolescent nicotine administration alters serotonin receptors and cell signaling mediated through adenylyl cyclase. Brain Res 951 (2002) 280-292
227. Wewers M.E., Dhatt R.K., Snively T.A., and Tejwani G.A. The effect of chronic administration of nicotine on antinociception, opioid receptor binding and met-enkelphalin levels in rats. Brain Res 822 (1999) 107-113
228. Brunzell D., Russell D.S., and Picciotto M. In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57BL/6J mice. J Neurochem 84 (2003) 1431-1441
229. Collins S.L., Wade D., Ledon J., and Izenwasser S. Neurochemical alterations produced by daily nicotine exposure in periadolescent vs. adult male rats. Eur J Pharmacol 502 (2004) 75-85
230. Li S., Kim K.Y., Kim J.H., Kim J.H., Park M.S., Bahk J.Y., et al. Chronic nicotine and smoking treatment increases dopamine transporter mRNA expression in the rat midbrain. Neurosci Lett 363 (2004) 29-32
231. Awtry T., and Werling L. Acute and chronic effects of nicotine on serotonin uptake in prefrontal cortex and hippocampus of rats. Synapse 50 (2003) 206-211
232. Houdi A.A., Dasgupta R., and Kindy M.S. Effect of nicotine use and withdrawal on brain preproenkephalin A mRNA. Brain Res 799 (1998) 257-263
233. Isola R., Zhang H., Tejwani G., Neff N., and Hadjiconstantinou M. Dynorphin and prodynorphin mRNA changes in the striatum during nicotine withdrawal. Synapse 62 (2008) 448-455
234. Mathieu-Kia A.M., and Besson M.J. Repeated administration of cocaine, nicotine and ethanol: effects on preprodynorphin, preprotachykinin A and preproenkephalin mRNA expression in the dorsal and the ventral striatum of the rat. Brain Res Mol Brain Res 54 (1998) 141-151
235. Katsura M., Ohkuma S., Xu J., Hibino Y., Tsujimura A., and Kuriyama K. Continuous treatment with nicotine increases diazepam binding inhibitor (DBI) and its mRNA in the mouse brain. Brain Res Mol Brain Res 55 (1998) 345-349
236. Yamazaki Y., Jia Y., Wong J., and Sumikawa K. Chronic nicotine-induced switch in SRC-family kinase signaling for long-term potentiation induction in hippocampal CA1 pyramidal cells. Eur J Neurosci 24 (2006) 3271-3284
237. Pandey S.C. Effects of chronic nicotine treatment on the expression of phospholipase C isozymes and the α subunit of gq/11 protein in the rat brain. Neurosci Lett 212 (1996) 127-130
238. Nisell M., Nomikos G.G., Chergui K., Grillner P., and Svensson T.H. Chronic nicotine enhances basal and nicotine-induced fos immunoreactivity preferentially in the medial prefrontal cortex of the rat. Neuropsychopharmacology 17 (1997) 151-161
239. Pich E.M., Pagliusi S.R., Tessari M., Talabot-Ayer D., Hooft van Huijsduijnen R., and Chiamulera C. Common neural substrates for the addictive properties of nicotine and cocaine. Science 275 (1997) 83-86
240. Marttila K., Raattamaa H., and Ahtee L. Effects of chronic nicotine administration and its withdrawal on striatal fosB/ΔfosB and c-fos expression in rats and mice. Neuropharmacology 51 (2006) 44-51
241. Pluzarev O., and Pandey S. Modulation of CREB expression and phosphorylation in the rat nucleus accumbens during nicotine exposure and withdrawal. J Neurosci Res 77 (2004) 884-891
242. Pandey S.C., Roy A., Xu T., and Mittal N. Effects of protracted nicotine exposure and withdrawal on the expression and phosphorylation of the CREB gene transcription factor in rat brain. J Neurochem 77 (2001) 943-952
243. Nuutinen S., Barik J., Jones I.W., and Wonnacott S. Differential effects of acute and chronic nicotine on Elk-1 in rat hippocampus. Neuroreport 18 (2007) 121-126
244. Blum M., Wu G., Mudó G., Belluardo N., Andersson K., Agnati L.F., et al. Chronic continuous infusion of (-)nicotine reduces basic fibroblast growth factor messenger RNA levels in the ventral midbrain of the intact but not of the 6-hydroxydopamine-lesioned rat. Neuroscience 70 (1996) 169-177
245. Kenny P.J., File S.E., and Rattray M. Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Brain Res Mol Brain Res 85 (2000) 234-238
246. Kane J.K., Konu O., Ma J.Z., and Li M.D. Nicotine coregulates multiple pathways involved in protein modification/degradation in rat brain. Brain Res Mol Brain Res 132 (2004) 181-191
247. Liu J.J., Mohila C.A., Gong Y., Govindarajan N., and Onn S.P. Chronic nicotine exposure during adolescence differentially influences calcium-binding proteins in rat anterior cingulate cortex. Eur J Neurosci 22 (2005) 2462-2474